Genetic manipulation confirmed p65 as a crucial nodal point in this regulatory network.<h4>Conclusion</h4>This study demonstrates that vericiguat exerts renoprotective, anti-inflammatory, and anti-fibrotic effects in CsA-induced CKD by modulating the NF-κB/TGF-β1 axis. Here, TGFB1 is linked to chronic kidney disease.